US Drug Recall Register
Class II · Moderate risk Terminated Initiated Dec 17, 2019 (7 years ago)

Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)

What was recalled

Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDC 0641-6043-01), 25 vials/shelf-pack (NDC 0641-6043-25), For IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.

Recalling firm
Hikma Pharmaceuticals USA Inc.
NDC code
0641-6043-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0658-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ketorolac recalls

See all